Markets › United States › NAS › MLAB

Mesa Laboratories Inc

NAS:MLABHealthcareCBOEFTSE:MRUTNASDAQ:INDS

$125.15+1.50%LiveIn session · ≈ AED 459.61 · Market cap $700.32M · Next earnings Thu 5 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	65.0%	59.2%	61.0%	61.6%	62.6%	63.5%	—	—
Operating margin	9.2%	2.6%	1.5%	−125.9%	6.8%	7.4%	7.4%	+0.0 pts
Net margin	2.4%	1.0%	0.4%	−117.6%	−0.8%	2.7%	2.7%	+0.0 pts
EBITDA margin	20.9%	17.6%	17.1%	−110.3%	17.6%	14.2%	—	—
Return on equity	0.8%	0.5%	0.2%	−174.9%	−1.2%	3.6%	3.6%	+0.0 pts
Return on assets	0.5%	0.3%	0.1%	−56.9%	−0.5%	1.6%	1.6%	+0.0 pts
Return on capital employed	2.2%	0.7%	0.5%	−67.6%	6.1%	5.1%	—	—
Debt / equity	0.4×	0.6×	0.5×	1.6×	1.1×	0.9×	0.9×	+0.0%
Debt / assets	24.4%	31.3%	28.1%	51.8%	41.9%	39.5%	—	—
Interest coverage	1.5×	1.2×	0.7×	−47.8×	1.4×	1.7×	—	—
Current ratio	9.3×	2.6×	2.7×	2.5×	0.6×	1.7×	1.7×	+0.0%
Quick ratio	9.0×	2.1×	1.9×	1.7×	0.5×	1.3×	—	—
Cash ratio	8.1×	1.0×	0.8×	0.6×	0.2×	0.4×	0.4×	+0.0%
Asset turnover	0.2×	0.3×	0.3×	0.5×	0.6×	0.6×	—	—
Inventory turnover	4.2×	3.1×	2.5×	2.5×	3.6×	3.4×	—	—
Receivables turnover	5.6×	4.5×	5.1×	5.5×	5.7×	5.6×	—	—
Dividend payout	96.7%	178.5%	366.2%	−1.4%	−175.7%	52.5%	—	—